July 8, 2025 Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum read more
CTAD 2024 Quanterix Fireside Chat with Henrik Zetterburg: Advances in Blood-Based Biomarkers for Alzheimer’s Disease read more
Consumer Affairs June 21, 2025 ‘Soccer head’ alters the brain even without concussion, study finds read more
June 20, 2025 Official Announcement – Winner of the Quanterix Abstract Contest (Spain & Portugal): “Neuroinflammatory Biomarkers Initiative: Funding for Research with Simoa Technology” read more
June 24, 2025 Blood Biomarkers Reveal the Hidden Story of Brain Injury: A New Era in Brain Health Monitoring read more
June 12, 2025 Unlocking Ultra-Sensitive Cytokine Detection: Insights from the Frontage & Quanterix Webinar read more
June 10, 2025 Refining the Alzheimer’s Biomarker Framework: Integrating p-Tau 205 and p-Tau 212 for Comprehensive Disease Profiling read more